Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Investigator Sponsored Study of Emphysematous Lung Sealant Therapy in Homogeneous Emphysema Using a Modified Treatment Strategy

NCT01728662 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT01728662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01728662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Investigator Sponsored Study of Emphysematous Lung Sealant Therapy in Homogeneous Emphysema Using a Modified Treatment Strategy
Lead sponsor
Rabin Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2012
Completion date
December 31, 2013
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with advanced homogeneous emphysema